Open AccessImpacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer
Author(s) -
Hiromichi Nakajima,
Kenichi Harano,
Tokiko Nakai,
Shota Kusuhara,
Takehiro Nakao,
Chikako Funasaka,
Chihiro Kondoh,
Nobuaki Matsubara,
Yoichi Naito,
Ako Hosono,
Shuichi Mitsunaga,
Genichiro Ishii,
Toru Mukohara
Publication year - 2022
Publication title -
the breast
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 78
eISSN - 1532-3080
pISSN - 0960-9776
DOI - 10.1016/j.breast.2022.01.002
Subject(s) - medicine , trastuzumab , oncology , metastatic breast cancer , trastuzumab emtansine , immunohistochemistry , breast cancer , hazard ratio , cancer , confidence interval , gastroenterology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom